The Massachusetts Life Sciences Center announced today that the agency’s Board of Directors has awarded $25 million in tax incentives to 33 life sciences companies. The recipient companies have committed to creating more than 1,200 new jobs in the Commonwealth in 2014.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.
